FOXA1在非小细胞肺癌组织中的表达及与癌转移相关性研究

doi:10.3877/cma.j.issn.2095-5820.2021.03.005

中华临床实验室管理电子杂志 ›› 2021, Vol. 09 ›› Issue (03) : 150 -153. doi: 10.3877/cma.j.issn.2095-5820.2021.03.005

实验研究

FOXA1在非小细胞肺癌组织中的表达及与癌转移相关性研究

薛兴阳¹^,^†(

), 蓝永权², 丁丹丹¹, 吴华振³, 罗志明¹, 赵健¹

^1. 510095　广东广州，广州医科大学附属肿瘤医院
^2. 510095　广东广州，广州医科大学附属肿瘤医院；514000　广东梅州，梅州市人民医院
^3. 510095　广东广州，广州医科大学附属肿瘤医院；511518　广东清远；清远市人民医院

收稿日期:2021-02-27 出版日期:2021-08-26
通信作者: 薛兴阳
基金资助:
广东省医学科研基金立项项目(A2015514); 广州市医药卫生科技一般引导项目(20151A011089)

FOXA1 expression in non-small cell lung cancer and its correlation with metastasis

Xingyang Xue¹^,^†(), Yongquan Lan², Dandan Ding¹, Huazhen Wu³, Zhiming Luo¹, Jian Zhao¹

^1. Department of Thoracic Surgery, Affiliated Cancer Hospital & Institute of Guangzhou Medical University, Guangzhou Guangdong 510095, China
^2. Department of Thoracic Surgery, Affiliated Cancer Hospital & Institute of Guangzhou Medical University, Guangzhou Guangdong 510095, China; Department of Chemotherapy, Meizhou People's Hospital, Meizhou Guangdong 514000, China
^3. Department of Thoracic Surgery, Affiliated Cancer Hospital & Institute of Guangzhou Medical University, Guangzhou Guangdong 510095, China; Department of Oncology Radiotherapy, The Sixth Affiliated Hospital of Guangzhou Medical University/Qingyuan People's Hospital, Qingyuan Guangdong 511518, China

Received:2021-02-27 Published:2021-08-26
Corresponding author: Xingyang Xue

全文 ( ) 下载PDF ( ) 导出引用

引用本文：

薛兴阳, 蓝永权, 丁丹丹, 吴华振, 罗志明, 赵健. FOXA1在非小细胞肺癌组织中的表达及与癌转移相关性研究[J]. 中华临床实验室管理电子杂志, 2021, 09(03): 150-153.

Xingyang Xue, Yongquan Lan, Dandan Ding, Huazhen Wu, Zhiming Luo, Jian Zhao. FOXA1 expression in non-small cell lung cancer and its correlation with metastasis[J]. Chinese Journal of Clinical Laboratory Management(Electronic Edition), 2021, 09(03): 150-153.

目的

探讨转录因子FOXA1在非小细胞肺癌的原发灶及转移灶中的表达情况及其与非小细胞肺癌转移的相关性。

方法

随机收集广州医科大学附属肿瘤医院2011年9月至2016年12月非小细胞肺癌病理确诊病例，包括非匹配的40例原发灶与40例转移灶组织标本、40例Ⅰ期及40例Ⅳ期患者原发灶组织标本，免疫组化法检测FOXA1表达及比较其在不同组织的差异情况。分析其中的12例既有原发灶又有转移灶的Ⅳ期非小细胞肺癌组织标本，比较FOXA1在同一病人原发灶和转移灶的表达差异情况。

结果

FOXA1主要表达于肿瘤细胞核，细胞质及胞膜无明显表达。在转移灶组织中FOXA1表达水平明显高于原发灶肺癌组织 (P＜0.05)。在Ⅳ期肺癌组织中FOXA1表达水平明显高于Ⅰ期肺癌组织 (P＜0.05)。在12例同一非小细胞肺癌病人原发灶及转移灶组织中，FOXA1在转移灶中表达高于原发灶，但P值未达到统计学意义。

结论

FOXA1与非小细胞肺癌转移可能相关，有望成为新的非小细胞肺癌治疗靶点。

关键词: FOXA1, 非小细胞肺癌, 免疫组织化学, 转移

Objective

To investigate the expression of FOXA1 in primary and metastatic non-small cell lung cancer (NSCLC) and its correlation with metastasis.

Methods

Patients with pathologically confirmed NSCLC from The Affiliated Cancer Hospital & Institute of Guangzhou Medical University from September 2011 to December 2016 were randomly collected, including mismatched tissue samples from 40 primary lesions and 40 metastatic lesions, and tissue samples from 40 stage Ⅰ and 40 stage Ⅳ patients. The expression of FOXA1 was detected by immunohistochemistry and the difference in different tissues was compared. The expression of FOXA1 in 12 cases of stage Ⅳ non-small cell lung cancer with both primary and metastatic tissues was analyzed.

Results

FOXA1 was mainly expressed in the nucleus, but not in the cytoplasm and membrane. In 40 pairs of lung cancer tissues and metastatic tissues, the expression level of FOXA1 in metastatic tissues was significantly higher than that in lung cancer tissues (P＜0.05). The expression level of FOXA1 in stage Ⅳ lung cancer tissue was significantly higher than that in stage Ⅰ lung cancer tissue (P＜0.05). The expression level of FOXA1 in primary and metastatic foci of 12 patients with NSCLC was different. The expression level of FOXA1 in metastatic foci was higher than that in primary foci, but the P value was not statistically significant.

Conclusion

FOXA1 may be related to the metastasis of NSCLC and is expected to become a new therapeutic target for NSCLC.

Key words: FOXA1, Non-small cell lung cancer, Immunohistochemistry, Metastasis

表1 NSCLC非匹配患者不同病灶中FOXA1表达情况(例)

项目	FOXA1表达		χ²	P 值
项目	低	高	χ²	P 值
非匹配患者的肺癌组织	33	7	13.653	0.000
非匹配患者的转移灶组织	17	23

表1 NSCLC非匹配患者不同病灶中FOXA1表达情况(例)

项目	FOXA1表达		χ²	P 值
项目	低	高	χ²	P 值
非匹配患者的肺癌组织	33	7	13.653	0.000
非匹配患者的转移灶组织	17	23

表2 FOXA1在NSCLC Ⅰ期及Ⅳ期肺癌原发灶组织中的表达情况(例)

项目	FOXA1表达		χ²	P 值
项目	低	高	χ²	P 值
Ⅰ期肺癌组织	33	7	4.013	0.045
Ⅳ期肺癌组织	25	15

表2 FOXA1在NSCLC Ⅰ期及Ⅳ期肺癌原发灶组织中的表达情况(例)

项目	FOXA1表达		χ²	P 值
项目	低	高	χ²	P 值
Ⅰ期肺癌组织	33	7	4.013	0.045
Ⅳ期肺癌组织	25	15

图1 FOXA1在病例52332中肺癌原发灶(上)及脑转移灶(下)中的表达情况

1	Bray F, Ferlay J, Soerjomataram I, et al. GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J]. CA Cancer J Clin, 2018, 68(6): 394-424.
2	Siegel RL, Miller KD, Goding Sauer A, et al. Colorectal cancer statistics, 2020[J]. CA Cancer J Clin, 2020, 70(3): 145-164.
3	Hirsch FR, Scagliotti GV, Mulshine JL, et al. Lung cancer: current therapies and new targeted treatments[J]. Lancet, 2017, 389(10066): 299-311.
4	Zhu T, Bao X, Chen M, et al. Mechanisms and Future of Non-Small Cell Lung Cancer Metastasis[J]. Front Oncol, 2020, 10: 585284.
5	Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation[J]. Cell, 2011, 144(5): 646-674.
6	Brix DM, Bundgaard Clemmensen KK, Kallunki T. Zinc Finger Transcription Factor MZF1-A Specific Regulator of Cancer Invasion[J]. Cells, 2020, 9(1): 223.
7	Parolia A, Cieslik M, Chu SC, et al. Distinct structural classes of activating FOXA1 alterations in advanced prostate cancer[J]. Nature, 2019, 571(7765): 413-418.
8	Huang C, Liu J, Xiong B, et al. Expression and prognosis analyses of forkhead box A (FOXA) family in human lung cancer[J]. Gene, 2019, 685: 202-210.
9	Adams EJ, Karthaus WR, Hoover E, et al. FOXA1 mutations alter pioneering activity, differentiation and prostate cancer phenotypes[J]. Nature, 2019, 571(7765): 408-412.
10	Cocce KJ, Jasper JS, Desautels TK, et al. The Lineage Determining Factor GRHL2 Collaborates with FOXA1 to Establish a Targetable Pathway in Endocrine Therapy-Resistant Breast Cancer[J]. Cell reports, 2019, 29(4):889-903.e810.
11	Liu B, Qin J, Shen W, et al. FOXA1 promotes proliferation, migration and invasion by transcriptional activating KRT7 in human gastric cancer cells.[J] J Biol Regul Homeost Agents, 2019, 33(4):1041-1050.
12	Katoh M, Katoh M. Human FOX gene family (Review)[J]. Int J Oncol, 2004, 25(5):1495-500.
13	Nakshatri H, Badve S. FOXA1 in breast cancer[J]. Expert Rev Mol Med, 2009, 11:e8.
14	Cirillo LA, Lin FR, Cuesta I, et al. Opening of compacted chromatin by early developmental transcription factors HNF3 (FoxA) and GATA-4[J]. Mol Cell, 2002, 9(2): 279-89.
15	Watanabe H, Francis JM, Woo MS, et al. Integrated cistromic and expression analysis of amplified NKX2-1 in lung adenocarcinoma identifies LMO3 as a functional transcriptional target[J]. Genes Dev, 2013, 27(2): 197–210.
16	Lin L, Miller CT, Contreras JI, et al. The hepatocyte nuclear factor 3 alpha gene, HNF3alpha (FOXA1), on chromosome band 14q13 is amplified and overexpressed in esophageal and lung adenocarcinomas[J]. Cancer Res, 2002, 62(18): 5273-5279.
17	Wang H, Meyer CA, Fei T, et al. A systematic approach identifies FOXA1 as a key factor in the loss of epithelial traits during the epithelial-to-mesenchymal transition in lung cancer[J]. BMC Genomics, 2013, 14: 680.
18	Deutsch L, Wrage M, Koops S, et al. Opposite roles of FOXA1 and NKX2-1 in lung cancer progression[J]. Genes Chromosomes Cancer, 2012, 51(6): 618-29.
19	Li J, Zhang S, Zhu L, et al. Role of transcription factor FOXA1 in nonsmall cell lung cancer[J]. Mol Med Rep, 2018, 17(1): 509-521.
20	Du H, Chen Y, Hou X, et al. PLOD2 regulated by transcription factor FOXA1 promotes metastasis in NSCLC[J]. Cell Death Dis, 2017, 8(10): e3143.
21	Ye JJ, Cheng YL, Deng JJ, et al. LncRNA LINC00460 promotes tumor growth of human lung adenocarcinoma by targeting miR-302c-5p/FOXA1 axis[J]. Gene, 2019, 685: 76-84.

[1]	孙帼, 谢迎东, 徐超丽, 杨斌. 超声联合临床特征的列线图模型预测甲状腺乳头状癌淋巴结转移的价值[J]. 中华医学超声杂志（电子版）, 2023, 20(07): 734-742.
[2]	武壮壮, 张晓娟, 史泽洪, 史瑶, 原韶玲. 超声联合乳腺X线摄影及PR、Her-2预测高级别与中低级别乳腺导管原位癌的价值[J]. 中华医学超声杂志（电子版）, 2023, 20(06): 631-635.
[3]	康夏, 田浩, 钱进, 高源, 缪洪明, 齐晓伟. 骨织素抑制破骨细胞分化改善肿瘤骨转移中骨溶解的机制研究[J]. 中华乳腺病杂志(电子版), 2023, 17(06): 329-339.
[4]	李雄雄, 周灿, 徐婷, 任予, 尚进. 初诊导管原位癌伴微浸润腋窝淋巴结转移率的Meta分析[J]. 中华普通外科学文献(电子版), 2023, 17(06): 466-474.
[5]	江艺, 张小进, 沈佳佳. 胆囊癌伴肝多发转移手术治疗（腹腔镜下胆囊癌切除+淋巴结清扫+肝Ⅴ、Ⅵ、Ⅶ段切除）[J]. 中华普通外科学文献(电子版), 2023, 17(06): 412-412.
[6]	唐旭, 韩冰, 刘威, 陈茹星. 结直肠癌根治术后隐匿性肝转移危险因素分析及预测模型构建[J]. 中华普外科手术学杂志(电子版), 2024, 18(01): 16-20.
[7]	袁育韬, 邢金琳, 谢克飞, 殷凯. CT征象及BRAF^V600E基因突变与甲状腺乳头状癌中央区淋巴结转移的相关性[J]. 中华普外科手术学杂志(电子版), 2023, 17(06): 611-614.
[8]	晏晴艳, 雍晓梅, 罗洪, 杜敏. 成都地区老年转移性乳腺癌的预后及生存因素研究[J]. 中华普外科手术学杂志(电子版), 2023, 17(06): 636-638.
[9]	徐成, 王璐璐, 王少华. 洗脱液甲状腺球蛋白在甲状腺乳头状癌转移淋巴结中的应用[J]. 中华普外科手术学杂志(电子版), 2023, 17(06): 701-704.
[10]	常剑, 邱峰, 毛郁琪. 摄食抑制因子-1与腹腔镜结直肠癌根治术后肝转移的关系分析[J]. 中华普外科手术学杂志(电子版), 2023, 17(05): 502-505.
[11]	肖体先, 刘骞, 宋京海. 乳房外Paget病脾转移一例报告[J]. 中华肝脏外科手术学电子杂志, 2023, 12(06): 717-719.
[12]	杨红杰, 张智春, 孙轶. 直肠癌淋巴结转移诊断研究进展[J]. 中华结直肠疾病电子杂志, 2023, 12(06): 512-518.
[13]	王小红, 钱晶, 翁文俊, 周国雄, 朱顺星, 祁小鸣, 刘春, 王萍, 沈伟, 程睿智, 秦璟灏. 巯基丙酮酸硫基转移酶调控核因子κB信号介导自噬对重症急性胰腺炎大鼠的影响及机制[J]. 中华消化病与影像杂志(电子版), 2023, 13(06): 422-426.
[14]	岳瑞雪, 孔令欣, 郝鑫, 杨进强, 韩猛, 崔国忠, 王建军, 张志生, 孔凡庭, 张维, 何文博, 李现桥, 周新平, 徐东宏, 胡崇珠. 乳腺癌HER2蛋白表达水平预测新辅助治疗疗效的真实世界研究[J]. 中华临床医师杂志(电子版), 2023, 17(07): 765-770.
[15]	孔凡彪, 杨建荣. 肝脏基础疾病与结直肠癌肝转移之间关系的研究进展[J]. 中华临床医师杂志(电子版), 2023, 17(07): 818-822.

阅读次数

全文

摘要

选择文件类型/文献管理软件名称

选择包含的内容

FOXA1 expression in non-small cell lung cancer and its correlation with metastasis

模态框（Modal）标题

选择文件类型/文献管理软件名称

选择包含的内容

FOXA1 expression in non-small cell lung cancer and its correlation with metastasis